Chemistry of Natural Products

   CONTENTS  

Foreword

Research Structures

Energy, Environment, and Biodiversity

Humanities and Ethics

Culture and Education

Society and Development

Information and Communication Technology

Biology and Health

Research Structures and Researchers

About

Home PUCRS TECNOPUC EDIPUCRS
Uk  Versão em Português  Uk  PDF Version  

From basic research to industry – the study of resveratrol

In 1999, the Laboratory of the Chemistry of Natural Products was created in the School of Chemistry, led by Professor André Arigony Souto. The group’s research areas are as follows: The evaluation of the biological activity of natural products, The development of nutraceutical formulations, and The development of analytical methodologies to quantify bioactive molecules in different types of matrices.

The main project, which began in 1999, studies the molecule resveratrol, which is present in wine and important in combating diseases linked to aging, such as cardiovascular diseases, neurodegenerative diseases (Alzheimer’s, Parkinson’s), and diabetes. In 2001, the Laboratory stood out when it published an article with data on the amount of resveratrol present in Brazilian red wines (information that previously did not exist in the Brazilian literature). An average of 2.5 mg/liter was discovered, which is a high level in comparison to the average for wines from other countries.

The next step, beginning in 2005, was the evaluation of different forms of resveratrol administration so that it could used as a pharmaceutical agent. In total, six patents were obtained, with two being the most important: one solved the problem of rapid elimination of resveratrol from the body (by means of a compound formed with another molecule, cyclodextrin, which slowly releases the resveratrol in the organism); the other developed the extraction process of resveratrol from a new natural source, the sorrel plant (Rumex acetosa), whose root contains a large amount of the molecule. The Laboratory sought a partnership in the pharmaceutical industry, and in 2008, it had its patents licensed by the company Eurofarma Laboratórios.

Currently, the main project of the Laboratory is to continue monitoring the processes with resveratrol. Currently, phase 1 clinical trials are starting (human testing for toxicity). If resveratrol passes through all the phases, it may reach the pharmaceutical market.